Abiraterone after docetaxel in metastatic castration-resistant prostate cancer (mCRPC) patients (p) in an off-protocol routine clinical setting.
Maria Ochoa de Olza
No relevant relationships to disclose
Albert Font
No relevant relationships to disclose
Nuria Sala
No relevant relationships to disclose
Miguel Beltran
No relevant relationships to disclose
Maria Pilar Barretina Ginesta
No relevant relationships to disclose
Olatz Etxaniz
No relevant relationships to disclose
Maria de los Llanos Gil
No relevant relationships to disclose
Xavier Garcia del Muro
No relevant relationships to disclose
Pamela Celiz
No relevant relationships to disclose
Jose R. Germa-Lluch
No relevant relationships to disclose